Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Nasopharyngeal Neoplasms 1Epstein-Barr Virus Infections 1

Interventions

Cisplatin 3Fluorouracil 2toripalimab 1pembrolizumab 1motexafin gadolinium 1dl1520 1Taxes 1Radiotherapy, Intensity-Modulated 1Radiotherapy 1Paclitaxel 1Oxaliplatin 1NVP-BKM120 1MVA vaccine 1L 778,123 1Irinotecan 1Immunohistochemistry 1Gemcitabine 1Fluorescent Antibody Technique 1Flow Cytometry 1EBV-associated membrane antigen, Epstein-Barr virus 1Doxorubicin 1Docetaxel 1Biopsy 1Aminolevulinic Acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Nasopharyngeal Neoplasms × MVA vaccine × Clear all
NCT01256853 2011-12-22

Modified Vaccinia Ankara (MVA) Vaccine Study

Chinese University of Hong Kong

Phase 1 Completed
18 enrolled
Head & Neck

Nasopharyngeal Neoplasms, Epstein-Barr Virus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡